Low-dose thrombolysis (20 mg alteplase over 6 hours) administered intravenously

Research studies on Low-dose thrombolysis (20 mg alteplase over 6 hours) administered intravenously - conditions it treats, mechanisms of action, and clinical outcomes from peer-reviewed literature.